![Chemical structure of 5-({4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl}methyl)-1,3-thiazolidine-2,4-dione, CAS 111025-46-8](https://api.angenesci.com/structure/3388/111025-46-8.png)
No data
No data
No data
| CAS Number | 111025-46-8 |
| Catalog Number | AG00HBSN(AGN-PC-0WAETD) |
| Chemical Name | 5-({4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl}methyl)-1,3-thiazolidine-2,4-dione |
| IUPAC Name | 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione |
| InChI | InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23) |
| InChI Key | HYAFETHFCAUJAY-UHFFFAOYSA-N |
| MDL Number | MFCD00865504 |
| Molecular Formula | C19H20N2O3S |
| Molecular Weight | 356.4387 |
| NSC Number | 758876 |
| SMILES | C(C)C=1C=CC(=NC1)CCOC1=CC=C(CC2C(NC(S2)=O)=O)C=C1 |
| Synonyms | 5-(4-(2-(5-ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione,
Actos,
AD 4833,
AD-4833,
AD4833,
pioglitazone,
Poglitazone Hydrochloride,
U 72107A,
U-72107A,
U72,107A,
U72107A,
Pioglitazone,
111025-46-8,
Actos,
Pioglitazona,
Pioglitazonum,
Glustin,
Zactos,
105355-27-9,
Pioglitazonum [INN-Latin],
Pioglitazona [INN-Spanish],
Duetact,
Pioglitazone [BAN:INN],
Pioglitazone [INN:BAN],
5-(4-(2-(5-ethylpyridin-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione,
U 72107,
AD-4833,
CHEBI:8228,
Pioglitazone (Actos),
HSDB 7322,
5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione,
Actos (TN),
C19H20N2O3S,
5-[4-[2-(5-ETHYL-2-PYRIDYL)ETHOXY]BENZYL]-2,4-THIAZOLIDINEDIONE,
U 72107A,
5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione,
AK-56326,
5-(4-(2-(5-ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione,
5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]thiazolidine-2,4-dione,
2,4-thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-,
105390-47-4,
Piozone,
Actost,
Pioglu,
U-72107,
2,4-Thiazolidinedione, 5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-, (+-)-,
[()-5-[[4-[2-(5-ethyl-2-pyridinyl) ethoxy] phenyl] methyl]-2,4-] thiazolidinedione monohydrochlorid,
pioglitazone (INN),
U72,107A,
5-{4-[2-(5-ethyl-2-pyridyl)ethoxy]benzyl}-2,4-thiazolidinedione,
SR-01000763737,
5-[[4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione,
pioglitazone-actos,
5-({4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl}methyl)-1,3-thiazolidine-2,4-dione,
HS-0047,
Spectrum_001623,
Spectrum2_001679,
Spectrum3_001002,
Spectrum4_001130,
Spectrum5_001480,
Spectrum5_002067,
AC1L1J1Q,
SCHEMBL4121,
BSPBio_002723,
KBioGR_001619,
KBioSS_002103,
MLS006011848,
SPBio_001897,
GTPL2694,
DTXSID3037129,
CTK5B5876,
KBio2_002103,
KBio2_004671,
KBio2_007239,
KBio3_001943,
KS-00000XMH,
HYAFETHFCAUJAY-UHFFFAOYSA-N,
HMS2089H14,
HMS3651D09,
HMS3712E16,
Pharmakon1600-01504401,
ACT02635,
BCP26474,
BBL029068,
BDBM50103521,
MFCD00865504,
NSC758876,
s2590,
STL309607,
STL373406,
(+/-)-5-[p-[2-(ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione,
5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione,
AKOS015894953,
AKOS022109420,
AC-1021,
API0009130,
CCG-220107,
CS-1700,
DB01132,
MCULE-2346786634,
NSC-758876,
RP17689,
RTX-010718,
SB17323,
(+/-)-5-[[4-[2-(5-Ethyl-2-pyridinyl)-ethoxy]phenyl]methyl]-2,4-thiazolidinedione,
NCGC00163128-01,
NCGC00163128-02,
NCGC00163128-03,
NCGC00163128-04,
NCGC00163128-05,
NCGC00163128-06,
NCGC00163128-07,
AN-15319,
AN-34016,
BC205345,
HY-13956,
SC-14147,
SMR002204015,
SBI-0206791.P001,
AB0004710,
AB1004597,
AB2000683,
DB-027350,
LS-151327,
FT-0601906,
FT-0645030,
ST24044191,
SW197561-3,
C07675,
D08378,
J10289,
K-0703,
AB00698454-10,
AB00698454_11,
AB00698454_12,
AB00698454_13,
355P279,
A801204,
I06-0089,
J-002506,
J-516181,
SR-01000763737-5,
BRD-A48430263-003-02-4,
BRD-A48430263-003-06-5,
I14-41886,
5-[4-[2-(5-ethyl-2-pyridyl) ethoxy]benzyl]-2,4-thiazolidinedione,
5-[4-[2-(5-ethyl-2-pyridyl)eth-oxy]benzyl]-2,4-thiazolidinedione,
5-{4-[2-(5-ethyl-2-pyridyl)ethoxy]benzyl}-2,4thiazolidinedione,
5-(4-(2-(5-ethylpyridin-2-yl)ethoxy)benzyl)-thiazolidine-2,4-dione,
5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione,
5-[[4-[2-(5-ethyl-2-pyridyl)ethoxy] phenyl]methyl]-2,4-thiazolidinedione,
2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]- (9CI),
2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-, (+/-)-,
5-[[4-[2-[(5-ethyl-2-pyridyl)]ethoxy]phenyl]methyl]thiazolidine- 2,4-dione,
5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-4-hydroxy-1,3-thiazol-2(5H)-one,
Pioglitazone HCl,
sepioglin,
Glidipion,
pioglitazone hydrochloride,
Lithium triflate,
Pioglitazone Krka,
Pioglitazone Ratio,
Glustin (TN),
Pioglitazone Actavis,
Zactos (TN),
Pioglitazone Ratiopharm,
Linagliptin/pioglitazone,
Poglitazone Hydrochloride,
PCG1,
UNII-X4OV71U42S,
Pioglitazone Actavis Group,
Pioglitazone Teva Generics,
CHEMBL595,
D02TNJ,
D03OFF,
D05CZG,
Pioglitazone Ratiopharm GmbH,
X4OV71U42S,
U-72107A,
AD 4833,
CID4829,
AD4833,
C19-H20-N2-O3-S,
CS-O-11716,
U72107A,
U-72107E,
1656B,
5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione,
C060836,
D000077205,
5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione,
627502-58-3,
(+-)-5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione,
(+-)-5-[p-[2-(ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione,
5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]benzylidene]-2,4-Thiazolidinedione,
9-(4'-(9h-carbazol-9-yl)biphenyl-4-yl)-9h-carbazole-3-carbaldehyde,
2,4-Thiazolidinedione, 5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-,
2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-(9CI),
5-[[4-[2-[(5-ethyl-2-pyridyl)]ethoxy]phenyl]methyl]thiazolidine-2,4-dione,
112529-15-4,
728045-10-1,
|
| Complexity | 466 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 356.119g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 25 |
| Hydrogen Bond Acceptor Count | 5 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 356.44g/mol |
| Monoisotopic Mass | 356.119g/mol |
| Rotatable Bond Count | 7 |
| Topological Polar Surface Area | 93.6A^2 |
| Undefined Atom Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 3.8 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302-H312-H332-H350-H360 |
| Packing Group | |
| Precautionary statements | P280 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

